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STUDY PROTOCOL Open Access
A brief CBT intervention for
depersonalisation/derealisation in
psychosis: study protocol for a feasibility
randomised controlled trial
Simone Farrelly1*, Emmanuelle Peters1,2, Matilda Azis4, Anthony David2,3 and Elaine C Hunter1,2
Abstract
Background: Depersonalisation is the experience of being detached or disconnected from one’s experience.
Studies suggest that clinically significant levels of depersonalisation are common in individuals who have psychotic
symptoms and are associated with increased impairment. However, to date, there have been no studies that have
investigated an intervention designed to target clinically significant depersonalisation in such patient groups. This
study aims to determine the feasibility and acceptability of a brief intervention targeting clinically significant
depersonalisation in those who also have current psychotic symptoms.
Methods/design: The feasibility of delivering six sessions of cognitive behavioural therapy for depersonalisation in
psychosis patients will be evaluated using a single-blinded randomised controlled trial with a treatment as usual
control condition. Participants will be assessed at baseline and then randomised to either the treatment or control
arm. Participants randomised to the treatment arm will be offered six sessions of individual cognitive behavioural
therapy delivered over a maximum of 10 weeks. Therapy will focus on an individualised shared formulation of
depersonalisation experiences and behavioural, cognitive, emotional regulation and thinking process strategies to
decrease distress associated with depersonalisation. Participants will be assessed again at a 10-week (post-
randomisation) follow-up assessment. The primary outcomes of interest will be those assessing the feasibility and
acceptability of the intervention including rates of referral, eligibility and acceptance to participate; attendance at
therapy sessions and completion of homework tasks; satisfaction with the intervention; maintenance of blinding;
and therapist competence. Secondary outcomes will be data on clinical outcome measures of depersonalisation
and positive symptoms of psychosis, anxiety, depression and post-traumatic stress.
Discussion: This study will determine the feasibility of delivering six sessions of cognitive behavioural therapy for
individuals with current psychotic symptoms who also experience clinically significant levels of depersonalisation.
The results will provide information to inform a larger randomised trial to assess intervention efficacy.
Trial registration: ClinicalTrials.gov NCT02427542
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Background
Psychosis is a general term covering a range of psychiatric
diagnoses such as schizophrenia, schizoaffective disorder
and delusional disorder [1]. Psychotic symptoms include
delusions, hallucinations, negative symptoms such as
affective flattening and cognitive disturbances. Recent esti-
mates suggest that four in every 1000 people in the United
Kingdom (UK) have a diagnosis of a psychotic condition
[2]. Alongside medication, current treatment guidelines
[1] recommend psychological intervention using either
cognitive behavioural therapy for psychosis (CBTp) or
family interventions. Recent meta-analyses have shown
some efficacy for CBTp [3]; however, prominent theorists
and clinicians have called for further treatment innova-
tions and understanding of the most efficacious treatment
components [4–6]. One such approach is the ‘the causal-
interventionalist’ approach [4], whereby a single hypothe-
sised maintenance factor is targeted with CBT in order to
reduce both this problem (e.g. worry, insomnia) with the
secondary gain of improving psychotic, and other emo-
tional, symptoms. Dissociation, and depersonalisation in
particular, may be one such maintenance factor.
Defining dissociation and depersonalisation
Dissociation is defined as ‘a disruption of and/or discon-
tinuity in the normal integration of consciousness, mem-
ory, identity, emotion, perception, body representation,
motor control and behaviour’ [7]. As such, it is an um-
brella term that incorporates a spectrum of phenomena
ranging from normal, everyday experiences such as ab-
sorption and divided attention to more distressing and
functionally impairing experiences of clinical significance
such as the psychiatric condition of depersonalisation
disorder (DPD).
Historically, all types of dissociative phenomena have
been viewed as part of a continuum, from ‘normative’
experiences to more pathological experiences. How-
ever, more recent theoretical reviews have suggested
that dissociation may be best considered as comprising
of two categories of phenomena: detachment and
compartmentalisation [8], although these are not ne-
cessarily mutually exclusive. ‘Detachment’ concerns a
person’s sense of separation from experience, including
from their sense of self (i.e. depersonalisation) or from
the external world (i.e. derealisation) [8, 9]. ‘Compart-
mentalisation’, on the other hand, is defined as a dis-
ruption in normally integrated functions that is not
accessible to conscious control and includes dissocia-
tive amnesia and somatoform dissociation [8]. This
study is primarily interested in the ‘detachment’ expe-
riences of depersonalisation and derealisation (referred
to as depersonalisation henceforth) in those with a
diagnosis of a psychotic disorder.
Prevalence estimates of depersonalisation
Depersonalisation symptoms are common in non-clinical
and clinical populations, particularly amongst those with
anxiety disorders where it is amongst the diagnostic cri-
teria of panic disorder and post-traumatic stress disorder
(PTSD) [10]. Epidemiological studies suggest lifetime
prevalence rates of transient depersonalisation symptoms
in the general population of between 26 and 74 % [11].
Community surveys examining the prevalence of DPD
specifically, using standardised diagnostic criteria, suggest
1 month prevalence rates of between 1.2 and 2.4 %, and
rates as high as 82.6 % have been reported comorbid with
other psychiatric disorders [11].
Dissociation and psychosis—common factors or pathway?
There has been an increasing interest in the presence of
dissociative experiences in psychotic disorders, in part due
to common aetiological factors of trauma and anxiety, and
the potential for dissociation to play a mediating role in
psychosis [12–14]. Dissociation has long been considered
a psychological defence mechanism to protect the individ-
ual against intolerable events such as trauma (see [14]). It
is also now well established that rates of trauma are high
in psychosis [15]. Recent population-based studies in both
the UK and the United States of America (USA) show
high rates of lifetime experiences of sexual and physical
abuse in those diagnosed with a psychotic disorder [16,
17]. Further, in a critical review of studies examining
trauma in those with severe mental illnesses, rates of
trauma exposure were between 49 and 100 % [18]. Con-
sidering the well-established link between trauma and
dissociation and the high rates of trauma experiences in
psychosis, it is therefore not surprising that dissociation is
also common in psychosis [19].
Additionally, the cognitive model of DPD [20] has
emphasised the role of anxiety and cognitive processes
common to anxiety disorders, in the development and
maintenance of DPD. Experimental research provides
support for the influence of cognitive processes of atten-
tion, catastrophic appraisals and attribution biases in
DPD [21]. Further, a longitudinal study of over 3000 par-
ticipants in the UK found that childhood anxiety was a
significant predictor of adult depersonalisation experi-
ences [22]. Likewise, cognitive models of psychosis [23]
emphasise the role of emotional processes, particularly
anxiety, in the onset and maintenance cycle of psychotic
symptoms [5, 24].
Considering the commonalities in maintenance pro-
cesses of dissociation and psychosis, it is understand-
able that dissociation is also common in psychosis, and
indeed, some authors have speculated that some
psychotic symptoms, in particular auditory hallucina-
tions, may actually be better understood as dissociative
in nature [12, 14].
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Rates of depersonalisation in psychosis
Eleven studies were identified by a review of research in-
vestigating dissociation in psychosis [25]. The reviewers
concluded that there was ‘solid empirical evidence’ that
individuals with a diagnosis of schizophrenia have more
frequent, and severe, dissociative experiences than non-
clinical populations but less frequent and severe than
those diagnosed with borderline personality disorder,
PTSD, or dissociative identity disorder. Furthermore,
they found a consistent association between experiences
of dissociation and severity of delusions and hallucina-
tions. However, there have been methodological flaws in
many of these studies as they used a general measure of
dissociation that includes aspects of amnesia, detachment
and more ‘normative’ dissociation such as absorption in
the same overall score. In this context, it is unclear pre-
cisely what aspects of dissociative experience were associ-
ated with psychosis.
More recently, a few studies have specifically investi-
gated depersonalisation experiences in psychosis. For
example, in a study of 147 inpatients with a diagnosis of
schizophrenia, 17 % were found to meet threshold criteria
for DPD. Similarly, studies examining depersonalisation
symptoms in schizophrenia suggest that depersonalisation
may be more common in those experiencing hallucina-
tions, compared to those with delusions only, and when
present are associated with more severe psychotic symp-
toms [26–28]. However, this is still an emerging field of
enquiry perhaps in part due to the ‘diagnostic oversha-
dowing’ of psychosis. In this context, there is only a
limited understanding of both the rates of DPD and the
phenomenology of depersonalisation in psychosis.
Depersonalisation—an anomalous experience in
psychosis?
One potential understanding of depersonalisation in
psychosis is of depersonalisation symptoms as an anom-
alous experience that is interpreted in a distressing man-
ner. In the cognitive behavioural therapy (CBT) model
of DPD [20], catastrophic appraisals of transient deper-
sonalisation experiences (such as of having damaged
one’s brain or of incipient ‘madness’) serve to exacerbate
and maintain symptoms. Similarly, in cognitive models
of psychosis (e.g. [29, 30]), appraisals of anomalous expe-
riences as personally relevant, threatening and/or attrib-
uted to an external cause are proposed to contribute to
the development of psychotic symptoms. Depersonalisa-
tion symptoms could be considered a type of anomalous
experience [23, 28], and although to the authors’ know-
ledge there are no empirical studies which have explored
the appraisals of depersonalisation symptoms in those
with psychosis, and in particular whether these symptoms
might give rise to psychotic explanations in the absence of
any alternative explanation for these phenomena, it may
be that this could be a factor that precipitates, and/or
maintains, psychosis.
A study of CBT for DPD [31] focused on generating less
threatening explanations for the depersonalisation symp-
toms and reducing symptom-focused attention, avoidance
and safety behaviours that were identified as maintaining
factors. This study showed significant improvements in the
experience of depersonalisation symptoms, depression and
anxiety, with a third of participants no longer meeting
threshold for DPD at the end of therapy. It is proposed that
a similar approach to depersonalisation symptoms in
psychosis might be effective in reducing the distress associ-
ated depersonalisation and may have a secondary impact of
psychotic symptoms. This approach is in line with the
‘causal-interventionist’ approach [4] which has been pro-
posed as the way forward for CBT for psychosis. To the au-
thors’ knowledge, there are no published studies or trials of
interventions for depersonalisation symptoms in psychosis.
Summary and research questions
Depersonalisation symptoms appear to be prevalent in
people diagnosed with psychotic disorders and when
present, depersonalisation symptoms are linked with more
severe psychotic symptoms. It is likely that negative ap-
praisals of these anomalous experiences might act to pre-
cipitate, maintain and exacerbate psychotic symptoms.
CBT has been found to be beneficial in patients with
chronic DPD, and it would be valuable to ascertain if simi-
lar approaches to target depersonalisation symptoms in
psychosis would be effective. This study aims to establish
the feasibility of a brief CBT-based intervention for deper-
sonalisation symptoms in people diagnosed with a psych-
otic disorder. The aim of the intervention would be to
alter negative attributions and distress associated with de-
personalisation experiences through psycho-education,
learning coping strategies such as ‘grounding’, changing at-
tentional biases and cognitive restructuring techniques to
modify appraisals. It is proposed that through reducing
distress, in particular, the maintenance cycle associated
with depersonalisation will be altered and thus overall de-
personalisation experiences reduced, with a possibility of
reducing psychotic phenomena in addition.
In this context there are two main research questions:
1. Will it be feasible to deliver a brief intervention for
depersonalisation symptoms in individuals with
current psychotic symptoms?
2. Will such an intervention be acceptable to individuals
who experience current psychotic symptoms?
Methods/design
This study aims to determine the feasibility and accept-
ability of a brief intervention for depersonalisation symp-
toms in those with current psychotic symptoms.
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The intervention will be evaluated using a single-blinded
(researcher blinded) randomised controlled trial (RCT) with
a treatment as usual control condition. Participants will be
assessed at baseline (T1) and then randomised to either the
treatment or control arm. Participants randomised to the
treatment arm will be offered six sessions of individual ther-
apy delivered over a maximum of 10 weeks (to allow for
non-attendance). All participants will be assessed again at a
10-week post-randomisation follow-up assessment.
Aims and objectives
The specific aims of the study are to establish:
– The feasibility of:
○ Recruitment, including eligibility rates and
acceptance rates and the randomisation process
○ Delivering a brief CBT intervention for DPD,
including attendance and completion rates
– The acceptability of the intervention for participants
including estimates of satisfaction and treatment
adherence
The secondary aim is to establish estimates of standard
deviations for outcomes of depersonalisation symptoms
to inform sample size calculations for a future trial.
Participants
We will seek to recruit 30 adults aged 18–70 with
current psychotic symptoms and whose depersonalisa-
tion symptoms meet threshold for DPD (i.e. over 75 on
the Cambridge Depersonalisation Scale (CDS)). We will
exclude those with insufficient capacity to provide
informed consent; insufficient proficiency in English
(spoken and written) to engage in CBT; a primary diag-
nosis of intellectual disability, head injury, substance
misuse or organic cause for psychosis; and those cur-
rently engaging in CBT or other psychotherapy.
Power calculation
As this is a feasibility study and the aim is to provide es-
timates of key parameters for a future trial rather than
to power the current study to detect statistically signifi-
cant differences, an a priori power calculation was not
conducted [32]. Instead, we aim to recruit sufficient par-
ticipants to provide reasonable estimates of study pa-
rameters. Based on the feasibility of recruitment, we aim
to recruit 30 participants. Two pieces of work enable es-
timation of the number of patients we would need to
screen in order to obtain 30 participants. Published re-
search with a similar sample [28] suggests that approxi-
mately 94 % of individuals diagnosed with a current
psychotic disorder will report at least one depersonalisa-
tion symptom, and 60 % will experience at least 10 de-
personalisation symptoms often. A recently completed
research study (Emma Davies, unpublished thesis, 2015)
recruiting people with psychosis from the same pools as
proposed for this trial suggests that approximately 50 %
of participants reporting depersonalisation symptoms
met criteria for DPD. In this context, we are likely to
need to screen 60 participants (assuming most individ-
uals will report at least one symptom and 50 % will score
above our threshold) to obtain our target sample. As it
is unlikely that all those contacted via initial letter will
respond and/or agree to be screened, we anticipate
attempting to contact approximately 100 individuals to
be able to screen 60.
Intervention
The intervention is based on the protocol developed for
CBT for DPD [31]. The intervention aims to reduce
distress associated with depersonalisation symptoms by al-
tering catastrophic attributions through psycho-education,
developing a shared understanding linking depersonalisa-
tion symptoms to anxiety and/or past traumas, enhancing
coping strategies (including grounding) and cognitive
restructuring techniques to modify unhelpful appraisals. It
is hypothesised that through reducing distress, in particu-
lar, the maintenance cycle associated with depersonalisa-
tion will be altered and thus overall depersonalisation
symptoms reduced.
The intervention will be delivered, in addition to treat-
ment as usual (see below) over six, 60-min sessions, cov-
ering the areas outlined in Table 1, as appropriate and
determined by the individual needs of the participant.
Sessions will be conducted at outpatient consulting
rooms closest to the participant or their home, depend-
ing on participant preference and needs.
The therapy will be delivered by SF, a clinical psych-
ologist in training under the supervision of EH, a
consultant clinical psychologist and developer of the
cognitive model of DPD [20]. In order to ensure the best
delivery of the intervention, the therapist (SF) will be
trained by EH. Regular supervision through the inter-
vention period of the study will be provided by EH. In
addition, to ensure the competence in CBT and fidelity
of the intervention, a random selection of 10 % audio re-
cordings of intervention sessions will be rated by EH
using a well-established adherence measure of CBT [33]
and a measure designed at the start of the study to cap-
ture fidelity to the depersonalisation protocol.
Treatment as usual control condition
For most participants, the treatment as usual will involve
regular contact with a care coordinator, medication and
regular reviews with a psychiatrist as provided for under
the care programme approach (CPA [34]).
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Procedure
Eligible participants will be recruited from a secondary
care mental health trust in South London (SLaM) and
will include community mental health teams, psycho-
logical therapies services and research registers.
Potential participants identified from the sources above
will be sent a letter of invitation and study information in
the post. The letter will provide detail of how to contact
the researcher should they be interested. If after 1 week,
there has been no contact from the participant, the first
author will telephone them, answer any questions they
may have about the study and offer an opportunity to be
screened for eligibility. This screening interview ask ques-
tions about current experiences of hallucinations and
paranoia or other delusions and will determine whether
they are likely to meet criteria for diagnosis of DPD using
the Cambridge Depersonalisation Scale [35]. Participants
passing this initial screen will then be invited to a face-to-
face interview with a researcher and be invited to provide
informed consent to participate in the study before par-
ticipating in the baseline assessment
All assessments will be conducted by an independent
research assistant, trained in the administration of mea-
sures and who will remain blind to treatment allocation;
maintenance of blinding will be collected at outcome
assessment. After the completion of the follow-up inter-
view, researchers will be unblinded and will re-contact
those who received the intervention to assess satisfaction
with and acceptability of the intervention. See Fig. 1 for
the trial flowchart.
Randomisation
An online randomisation service will be used to allocate
participants to either the intervention group or control.
Randomisation will use randomly permuted blocks to
ensure equal allocation to each group. After the baseline
interview, the first author will enter the participant’s de-
tails into the online service and will receive an automatic
email which details the allocation of the participant. The
first author will then contact the participant to alert
them of their allocation and, if the CBT/active interven-
tion group, will arrange first therapy session. The RA
will be kept blinded to the allocation to reduce bias.
Data collection
The primary outcomes of this trial are the estimates of
feasibility and acceptability.
To establish the feasibility of conducting a future trial,
the following data will be collected throughout the re-
cruitment and intervention process:
– Referral (number of participants referred to the study)
– Eligibility rates (number of referred and approached
participants who meet study entrance criteria)
– Acceptance rates (number of participants consenting
to the study) and reasons for study refusals
– Participant attendance rates at sessions and duration
of intervention (i.e. number of weeks taken to attend
six sessions)
– Data attrition (proportion of outcome data obtained)
– Feasibility of randomisation process (maintenance of
researcher blindness to treatment allocation)
– Therapist competence, CBT fidelity and CBT for
DPD
To establish the acceptability of the intervention, in
addition to the data above, attrition rates (number of
treatment sessions completed by participants, number of
therapy drop outs (i.e. completing two or fewer sessions)
and percent of homework tasks completed) will be col-
lected throughout the intervention.
After the follow-up interview is completed and scored,
researchers will be unblinded and all intervention partici-
pants will be interviewed about their impressions of the
intervention. The interview will collect data on their im-
pressions of and satisfaction with the intervention using
questions based on the Satisfaction of Therapy Question-
naire [36], altered to capture aspects of improvement/satis-
faction related to depersonalisation symptoms. Participants
will be asked to rate on a five-point Likert scales:
○ Their expectations and actual progress made on
dealing with depersonalisation
○ Their level of satisfaction with the therapy, therapist
and tasks between therapy
Table 1 Components of CBT intervention
Psycho-education/shared formulation
• Psycho-education about depersonalisation
• Individualised CBT shared formulations for current pattern of
depersonalisation
• Assessing factors which influence fluctuations in severity
• Rationale for keeping a diary for homework
• Example of diary completion
Behavioural
• Planning and testing impact of environmental/behavioural changes
to manipulate and manage depersonalisation symptoms
Emotion regulation
• Examining the role of emotions associated with depersonalisation
• Identifying anxiety/distress management strategies
• Psycho-education about grounding strategies and practice of these
Cognitive
• Identifying unhelpful thoughts about depersonalisation
• Cognitive restructuring—reviewing the evidence for and against
unhelpful depersonalisation related thoughts
Thinking processing
• Role of attention in maintaining depersonalisation
• Reducing hyper-vigilance/symptom monitoring/checking behaviours
• Acceptance and mindfulness approaches to depersonalisation
Review and relapse prevention
• Summary of what has been learnt from the sessions
• Depersonalisation action plan
After each session, participants will be given a small ‘homework’ task to
practice techniques introduced in the session and to monitor symptoms
using a diary
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○ The extent to which they gained new skills and
knowledge during the intervention
○ Their relationship to the therapist including therapist
competence, sympathy, caring nature and
supportiveness
There will be four additional open questions to deter-
mine the aspects of the intervention the participants
found most and least helpful, their views on whether the
intervention met their expectations overall and an oppor-
tunity to make any other comments.
Clinical data
Clinical and demographic data will be collected at base-
line interview and will include sex, age, ethnicity, marital
status, education, employment status, medication use,
age of onset of both DP/DR and psychotic symptoms,
current clinical diagnosis and past experience of cogni-
tive behavioural therapy or other psychotherapeutic ap-
proaches. Data will be collected at baseline assessment
and at an outcome interview at 10 weeks.
Secondary, clinical outcome data will be collected to
estimate key parameters to inform future trial design. Out-
comes include depersonalisation, psychotic, depression
and anxiety symptoms, as well as screening for post-
traumatic stress disorder.
– Cambridge Depersonalisation Scale (CDS; [35]). The
CDS is a 29-item scale that measures the severity of
trait depersonalisation symptoms over the preceding
6 months. For each item, frequency (Likert scale
0 = never to 4 = all the time) and duration (Likert scale
1 = few seconds to 6 =more than a week) are collected;
each item maximum is therefore 10. A total scale score
is the sum of each item, with a maximum of 290.
Scores greater than 70 have been shown to reliably
predict a clinical diagnosis of DPD using DSM criteria.
In order to measure change, the wording of the trait
CDS will be changed to measure the severity of DP/DR
symptoms over the preceding month. The level of
distress, preoccupation, impairment and understanding
of depersonalisation symptoms will also be collected.
– The Psychotic Symptom Rating Scale (PSYRATS;
[37]). The PSYRATS will be used to monitor
changes in psychotic symptomatology between
baseline assessment and outcome interview. The
PSYRATS consists of two subscales measuring the
presence and typology, beliefs/conviction, distress
and disruption associated with auditory
hallucinations and delusions. The auditory
hallucination (AH) subscale has 11 items and the
delusions (DELs) subscale has six items. All items
are scored between 0 and 4. For example, for item 1
Fig. 1 Trial flowchart
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in the AH scale, 0 = voices are not present to 4 =
voices are present continuously… The maximum
score for the AH and DELs subscales are 44 and 24,
respectively.
– Beck Depression Inventory (BDI; [38]). The BDI-II is a
21-item self-report scale, rated on a 4-point Likert scale
(0 = symptom not present to 3 = symptom present with
significant distress/impairment) measuring common
symptoms of depression. Total scores range from 0 to
63. Total scores of less than 13 indicate minimal
depression, scores 14–19 indicate mild depression,
scores 20–28 indicated moderate depression and scores
above 29 indicate severe depression.
– Beck Anxiety Inventory (BAI; [39]). The BAI is a
21-item self-report scale with the same scoring.
Total scores are interpreted as follows: 0–9 indicates
minimal anxiety; 10–16 indicates mild anxiety;
17–29 indicates moderate anxiety; and 30–63
indicates severe anxiety.
– Post-traumatic Diagnosis Scale (PDS; [40]. The PDS
has 49 items including a checklist of potentially
traumatising events and an indication of the distress,
intrusive thoughts, avoidance and hyperarousal in
the last month. There is a total score ranging from 0
to 51 with 1–10 considered ‘mild’, 11–20 ‘moderate’,
21–35 moderate to severe and greater than 36
severe.
– Structured clinical interview for DSM-IV dissociative
disorders (SCID-D) [41]. It includes nine items
addressing the presence and frequency of common
depersonalisation symptoms, the duration and
frequency of the most severe instance of depersonalisa-
tion, functional impairment, distress and exclusionary
criteria such as not the result of drugs, organic issues
and does not occur exclusively in the context of other
psychiatric condition such as psychosis.
Analyses
As this is a feasibility study, the analyses will be primar-
ily descriptive aiming to provide estimates of feasibility
parameters and to inform power calculations for a future
trial. Descriptions of continuous data, including clinical
data and sample characteristics, will be provided using
mean, SD, median and IQR. Frequencies and propor-
tions will be used to analyse categorical variables.
Feasibility of trial procedures will be assessed using
proportions and their estimated 95 % confidence inter-
vals (CIs) for rates of the following: referral (number of
referrals divided by total approached); eligibility (number
of eligible participants divided by number screened and
number approached); acceptance (number screened
divided by number approached and number consented
divided by number approached); attendance (average
number of treatment sessions attended and average
number of weeks taken to complete intervention); data
attrition (proportion of outcome data obtained); and
maintenance of blinding (incidences of unblinding of re-
searcher divided by number of follow-up assessments).
Therapist competence will be presented as proportion
with estimated 95 % confidence intervals for the total
score divided by applicable items on the CTRS and DPD
fidelity measure. Acceptability of trial procedures will be
assessed using proportions and their estimated 95 %
confidence intervals for rates of: attrition (proportion of
treatment sessions completed and of homework tasks
completed), expectations and actual progress (propor-
tion rating at each point on Likert scale) and satisfaction
with therapy, therapist and tasks (proportion rating at
each point on Likert scale).
Population variances will be determined using the
upper 80th nonparametric bootstrap percentile of confi-
dence intervals around the estimates [42].
Adverse events
We do not anticipate any serious adverse events as a re-
sult of this psychological intervention, but all adverse
events will be collected, discussed in supervision and re-
ported to regulatory authorities as required.
Discussion
This paper presents the protocol for a study to assess
the feasibility and acceptability of a brief cognitive be-
havioural therapy intervention for individuals who
have depersonalisation symptoms in the context of
psychotic symptoms. The intervention, based on that
developed for DPD, will focus on providing an individ-
ual cognitive formulation and explanation of deper-
sonalisation experiences and developing behavioural,
cognitive, emotional regulation and thinking process-
ing changes or strategies to decrease the associated
distress. The findings from this study will help esti-
mate the key parameters for a future trial.
Trial status
Recruitment to the trial is underway and is due to be
completed in March 2016. The first participant was ran-
domised in June 2015.
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